Molecular-Based Magnetic Resonance Multimodal Probes for Tumor Biomarker Imaging

Jian Zhang1,2, Mou Jiang1, Long Xiao1,2

  • 1State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, P. R. China.

Insights

Small-molecule probes enhance magnetic resonance imaging (MRI) for cancer detection by targeting the tumor microenvironment (TME). These advanced probes improve sensitivity and precision for personalized oncology.

Area of Science:

  • Oncology
  • Biomedical Imaging
  • Chemical Biology

Background:

  • Cancer poses a significant global health burden, with the tumor microenvironment (TME) playing a critical role in its progression.
  • Magnetic resonance imaging (MRI) offers excellent soft-tissue contrast but suffers from low sensitivity for detecting TME biomarkers.
  • There is a need for advanced imaging strategies to overcome MRI's limitations for early cancer detection and therapeutic monitoring.

Purpose of the Study:

  • To review recent design strategies for small-molecule responsive probes.
  • To highlight the potential of these probes in multimodal imaging for cancer diagnostics.
  • To discuss the future of MR-based multimodal agents in precision oncology.

Main Methods:

  • Systematic review of recent literature on small-molecule responsive probes for TME imaging.
  • Analysis of multimodal imaging strategies integrating MRI with other modalities.
  • Evaluation of probe design principles focusing on pharmacokinetics and targeting precision.

Main Results:

  • Small-molecule multimodal probes offer advantages over nanoparticle-based agents in pharmacokinetics and targeting precision.
  • TME-responsive probes can bridge the gap between molecular recognition and macroscopic in vivo imaging.
  • Multimodal imaging strategies consolidate multidimensional data for enhanced cancer visualization.

Conclusions:

  • Small-molecule responsive probes represent a promising avenue for improving MRI sensitivity and specificity in oncology.
  • These probes are crucial for early cancer detection and longitudinal monitoring of therapeutic responses.
  • MR-based multimodal agents are poised to become essential tools for advancing personalized precision oncology.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...